Explanation:
R.A. 9502 of 2008, the Cheaper Medicines Act, is intended to achieve universally accessible and cheaper and quality medicines by pursuing an effective competition policy in the pharmaceutical sector. The President subsequently issued an executive order requiring maximum retail prices for a number of drugs.
